Andere Kunden interessierten sich auch für
![Management of Pancreatic Diseases, An Issue of Gastroenterology Clinics of North America]( "Management of Pancreatic Diseases, An Issue of Gastroenterology Clinics of North America")
Management of Pancreatic Diseases, An Issue of Gastroenterology Clinics of North America63,99 €![Nutritional Management of Gastrointestinal Diseases, an Issue of Gastroenterology Clinics of North America]( "Nutritional Management of Gastrointestinal Diseases, an Issue of Gastroenterology Clinics of North America")
Nutritional Management of Gastrointestinal Diseases, an Issue of Gastroenterology Clinics of North America63,99 €![Helicobacter Pylori Infection: Pathophysiology, Epidemiology and Management]( "Helicobacter Pylori Infection: Pathophysiology, Epidemiology and Management")
Helicobacter Pylori Infection: Pathophysiology, Epidemiology and Management134,99 €![Helicobacter Pylori in Human Diseases]( "Helicobacter Pylori in Human Diseases")
Helicobacter Pylori in Human Diseases145,99 €![Clinical Aspects of Helicobacter Pylori Infection]( "Clinical Aspects of Helicobacter Pylori Infection")
Clinical Aspects of Helicobacter Pylori Infection153,99 €![Pulmonary Manifestations of Pediatric Diseases, an Issue of Pediatric Clinics of North America]( "Pulmonary Manifestations of Pediatric Diseases, an Issue of Pediatric Clinics of North America")
Pulmonary Manifestations of Pediatric Diseases, an Issue of Pediatric Clinics of North America40,99 €![Allergic Skin Diseases, An Issue of Immunology and Allergy Clinics of North America]( "Allergic Skin Diseases, An Issue of Immunology and Allergy Clinics of North America")
Allergic Skin Diseases, An Issue of Immunology and Allergy Clinics of North America63,99 €
Helicobacter pylori (H. pylori) infection is a worldwide disease with a significant morbidity and mortality; it is the leading cause of non-ulcer dyspepsia, peptic ulcers and gastric tumors, including low-grade mucosa-associated lymphoid tissue-lymphoma and adenocarcinoma. In addition, it has also been recognized that the interaction between H. pylori and non-steroidal, anti-inflammatory drugs is damaging to the gastroduodenal mucosa. H. pylori treatment still remains a challenge for physicians, since no current first-line therapy is able to cure the infection in all treated patients. This issue will serve to update gastroenterologists on current therapies, evaluation and management of disease progression, and the future of management of H. pylori infection.